Showing results (411-420 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|May 8, 2024
Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetesPatrick P Gleason, Benjamin Y Urick, Landon Z Marshall, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE StudyCindy Garris, Maral DerSarkissian, Rose Chang, et al.Journal of Managed Care & Specialty Pharmacy|January 28, 2021
Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision treeStephen C Ijioma, Vasco M Pontinha, David A Holdford, et al.Journal of Managed Care & Specialty Pharmacy|January 31, 2022
Social determinants of health and adult influenza vaccination: a nationwide claims analysisJustin Gatwood, Sujith Ramachandran, Sohul A Shuvo, et al.Journal of Managed Care & Specialty Pharmacy|February 21, 2018
AMCP Partnership Forum: Improving Quality, Value, and Outcomes with Patient-Reported OutcomesJournal of Managed Care & Specialty Pharmacy|November 25, 2022
Cost impact of different treatment regimens of brolucizumab in neovascular age-related macular degeneration: A budget impact analysisZasim Azhar Siddiqui, Trupti Dhumal, Jay Patel, et al.Journal of Managed Care & Specialty Pharmacy|June 24, 2026
Real-world treatment patterns, resource use, and costs in human epidermal growth factor receptor 2-negative advanced gastric/gastroesophageal junction cancer in the United States in the immune checkpoint inhibitor eraZiyan Chen, Wei Song, Jenna Abdelhadi, et al.Journal of Managed Care & Specialty Pharmacy|June 24, 2026
Association between comorbid depression, antidepressant adherence, and disease-modifying therapy adherence among Texas Medicaid patients with sickle cell diseaseBlessing I Okoye, Jamie C Barner, Hyeun Ah Kang, et al.Journal of Managed Care & Specialty Pharmacy|June 26, 2026
AMCP Market Insights: Managed care considerations in Barth syndromeBridget Flavin, Hilary J Vernon, W Todd Cade, et al.Journal of Managed Care & Specialty Pharmacy|May 29, 2026
Patient experience data in formulary decision-making: Payer-reported perceptions and useSteven Kheloussi, Iyar Mazar, Magdalena Harrington, et al.Pageof 185